MAPT and Alzheimer disease: We tested four AD endophenotypes in A4 (Aβ PET, tau PET, hippocampal volume [HV; a marker of neurodegeneration], and Preclinical Alzheimer Cognitive Composite [PACC]52; Supplementary Table 17).